The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Retrospective analysis of pathological response in colorectal cancer liver metastases following treatment with bevacizumab: Updated findings.
Ruth Vera
No relevant relationships to disclose
Joan Figueras
Consultant or Advisory Role - Roche
Honoraria - Roche
Marisa Gomez Dorronsoro
No relevant relationships to disclose
Santiago Lopez Ben
Honoraria - Roche
Antonio Viudez
No relevant relationships to disclose
Bernardo Queralt
Honoraria - Roche
Irene Hernandez
No relevant relationships to disclose
Jordi Soriano
Honoraria - Roche
Cruz Zazpe
No relevant relationships to disclose
Rosa Maria Ortiz Duran
Honoraria - Roche